AvePoint chief legal officer sells 40,000 shares

AvePoint, Inc. director and chief legal officer Brian Michael Brown reported open-market sales of 40,000 shares of common stock on July 14–15, 2026, at prices of $13.00 and $13.18 per share.

Accepted by SEC EDGAR 07/16/2026 - 04:33 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

AvePoint, Inc. director and chief legal officer Brian Michael Brown reported open-market sales of 40,000 shares of common stock on July 14–15, 2026, at prices of $13.00 and $13.18 per share. The transactions were executed under a Rule 10b5-1 trading plan adopted on December 16, 2025, and Brown continues to hold 819,664 shares, including vested and unvested RSUs.

Insider Trade Summary 10b5-1

Net Seller: 40,000 shares

Net Sell 2 txns

Insider Brown Brian Michael

Role Chief Legal Officer

Sold 40,000 shs ($526K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	31,631	$13.18	$417K
Sale	Common Stock F1, F2	8,369	$13.00	$109K

Holdings After Transaction: Common Stock — 819,664 shares (Direct)

Footnotes (2)

1. F1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.
2. F2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, March 18, 2025, and March 18, 2026.

Key Figures

Total shares sold: 40,000 shares Sale on July 15, 2026: 31,631 shares at $13.18 per share Sale on July 14, 2026: 8,369 shares at $13.00 per share +2 more

5 metrics

Total shares sold 40,000 shares Aggregate insider sales by Brian Michael Brown per transaction summary

Sale on July 15, 2026 31,631 shares at $13.18 per share Open-market sale of AvePoint common stock on 2026-07-15

Sale on July 14, 2026 8,369 shares at $13.00 per share Open-market sale of AvePoint common stock on 2026-07-14

Post-transaction holdings 819,664 shares Shares beneficially owned by Brown after the July 15, 2026 sale

Rule 10b5-1 plan adoption date December 16, 2025 Date Brown adopted the trading plan used for these sales

Key Terms

Rule 10b5-1 trading plan, non-RSU common stock, vested RSUs, unvested RSUs

4 terms

Rule 10b5-1 trading plan regulatory

"The sale transaction reported ... was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

non-RSU common stock financial

"Includes non-RSU common stock as well as aggregate vested and unvested RSUs"

vested RSUs financial

"Includes non-RSU common stock as well as aggregate vested and unvested RSUs"

unvested RSUs financial

"Includes non-RSU common stock as well as aggregate vested and unvested RSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AvePoint (AVPT) report for Brian Michael Brown?

AvePoint (AVPT) reported that Brian Michael Brown, its chief legal officer and director, executed open-market sales of company common stock. These sales occurred over two days and were carried out under a Rule 10b5-1 trading plan previously adopted by Brown.

How many AvePoint (AVPT) shares did Brian Michael Brown sell and at what prices?

Brian Michael Brown sold a total of 40,000 AvePoint (AVPT) shares of common stock. He sold 8,369 shares at $13.00 per share on July 14, 2026, and 31,631 shares at $13.18 per share on July 15, 2026, in open-market transactions.

How many AvePoint (AVPT) shares does Brian Michael Brown hold after the reported sales?

After the reported sales, Brian Michael Brown holds 819,664 AvePoint (AVPT) shares. This post-transaction figure reflects his remaining economic interest, including both non-RSU common stock and vested and unvested RSUs subject to previously disclosed vesting schedules.

Were Brian Michael Brown’s AvePoint (AVPT) share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sale transactions were effected under a Rule 10b5-1 trading plan for AvePoint (AVPT) stock. This plan was adopted on December 16, 2025, indicating the trades were pre-arranged rather than opportunistic market-timing decisions.

Do Brian Michael Brown’s remaining AvePoint (AVPT) holdings include RSUs?

Yes. The reported 819,664 AvePoint (AVPT) shares include both non-RSU common stock and the aggregate of Brown’s vested and unvested RSUs. These RSUs remain subject to the vesting schedules described in earlier AvePoint Form 4 reports.

What proportion of AvePoint (AVPT) insider activity in this filing involved sales versus purchases?

All reported AvePoint (AVPT) insider activity in this filing consists of sales. The transaction summary shows 2 sale transactions totaling 40,000 shares sold, with no reported purchases, derivative exercises, gifts, or tax-withholding entries for this period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brown Brian Michael

(Last) (First) (Middle)

C/O AVEPOINT, INC.

901 E BYRD ST, SUITE 900

(Street)

RICHMOND VIRGINIA 23219

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/14/2026		S		8,369(1)	D	$13	851,295(2)	D
Common Stock	07/15/2026		S		31,631(1)	D	$13.18	819,664(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.

2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, March 18, 2025, and March 18, 2026.

	/s/ Brian Michael Brown	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)